Close Menu

NEW YORK — T2 Biosystems said today that the US Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-on Payment (NTAP) for the company's T2Bacteria sepsis panel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.